Meeting
2014 Palliative and Supportive Care in Oncology Symposium
Prevalence and correlates of patient symptom burden at initiation of curative chemotherapy.
Authors
Caitlin McCarty
Massachusetts General Hospital, Boston, MA
Caitlin McCarty, Lara Traeger, Joseph A. Greer, Jennifer S. Temel, Theresa Margaret McDonnell
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: End-of-Life Care, <span>Patient-Reported Outcomes</span>, and Survivorship
Track
Survivorship,Patient-Reported Outcomes: Mechanisms of Symptoms and Treatment Toxicities,Early Integration of Palliative Care in Cancer Care,Psycho-oncology,End-of-Life Care
Sub Track
Patient-Reported Outcomes: Mechanisms of Symptoms and Treatment Toxicities
Citation
J Clin Oncol 32, 2014 (suppl 31; abstr 176)
DOI
10.1200/jco.2014.32.31_suppl.176
Abstract #
176
Poster Bd #
E9
Abstract Disclosures
Similar Posters
Poster
2014 Palliative and Supportive Care in Oncology Symposium
Frequency and characteristics of cancer-related drowsiness (CRD or excessive daytime sleepiness) in patients with advanced cancer: Results of a prospective survey at a tertiary cancer center.
First Author: Sriram Yennu
First Author: S. K. Patel
Poster
2022 ASCO Annual Meeting
Longitudinal screening for depression and anxiety in prostate cancer (PC) and association with disease and treatment factors.
First Author: Risa Liang Wong
Poster
2021 ASCO Annual Meeting
Factors associated with use of medications for anxiety and depression in testicular cancer survivors after cisplatin-based chemotherapy.
First Author: Shirin Ardeshirrouhanifard